Article

Marijuana Hazard: Stress Cardiomyopathy

Author(s):

Using marijuana may double the risk of stress cardiomyopathy, researchers found.

Even as states move to legalize the use of cannabis, researchers are just beginning to track its physiological impact on users.

In a study presented today at the American Heart Association's Scientific Sessions in New Orleans, LA, Amitoj Singh, MD, and colleagues at St. Luke's University Health Network in Bethlehem, PA, found it can have a harmful effect on the heart.

In a retrospective study, the authors found younger marijuana users were twice as likely as non-users to experience stress cardiomyopathy, a sudden weakening of the heart muscle. The condition is usually temporary, but can result in cardiac arrest and to require an implanted defibrillator.

Compared with non-users, researchers found that marijuana users were more likely to be younger, male, and have few cardiovascular risk factors such as high blood pressure, diabetes and high cholesterol. That meant they were unlikely to develop stress cardiomyopathy, but some of those who used marijuana did.

The researchers found that 2.4% of the marijuana users were likely to go into cardiac arrest after a bout of cardiomyopathy than controls (2.4% vs. 0.8%).

Marijuana users were also far more likely than non-users to have a history of depression (32.9% vs. 14.5%) to smoke tobacco (73.3% vs. 28.6%) and to use multiple substances (11.4%. vs. 0.3%).

Those habits add to the likelihood of developing stress cardiomyopathy so the researchers adjusted for known risk factors to isolation the association between marijuana use and the heart condition.

Among the study limits are the facts that the researchers could not determine how much marijuana the subjects were using or the time between its use and the incidents of cardiomyopathy.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.